首页> 美国卫生研究院文献>Springer Open Choice >Benchmark dose analyses of multiple genetic toxicity endpoints permit robust cross-tissue comparisons of MutaMouse responses to orally delivered benzoapyrene
【2h】

Benchmark dose analyses of multiple genetic toxicity endpoints permit robust cross-tissue comparisons of MutaMouse responses to orally delivered benzoapyrene

机译:多个遗传毒性终点的基准剂量分析可对MutaMouse对口服递送的苯并a py的反应进行可靠的跨组织比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Genetic damage is a key event in tumorigenesis, and chemically induced genotoxic effects are a human health concern. Although genetic toxicity data have historically been interpreted using a qualitative screen-and-bin approach, there is increasing interest in quantitative analysis of genetic toxicity dose–response data. We demonstrate an emerging use of the benchmark dose (BMD)-approach for empirically ranking cross-tissue sensitivity. Using a model environmental carcinogen, we quantitatively examined responses for four genetic damage endpoints over an extended dose range, and conducted cross-tissue sensitivity rankings using BMD100 values and their 90% confidence intervals (CIs). MutaMouse specimens were orally exposed to 11 doses of benzo[a]pyrene. DNA adduct frequency and lacZ mutant frequency (MF) were measured in up to 8 tissues, and Pig-a MF and micronuclei (MN) were assessed in immature (RETs) and mature red blood cells (RBCs). The cross-tissue BMD pattern for lacZ MF is similar to that observed for DNA adducts, and is consistent with an oral route-of-exposure and differences in tissue-specific metabolism and proliferation. The lacZ MF BMDs were significantly correlated with the tissue-matched adduct BMDs, demonstrating a consistent adduct conversion rate across tissues. The BMD CIs, for both the Pig-a and the MN endpoints, overlapped for RETs and RBCs, suggesting comparable utility of both cell populations for protracted exposures. Examination of endpoint-specific response maxima illustrates the difficulty of comparing BMD values for a fixed benchmark response across endpoints. Overall, the BMD-approach permitted robust comparisons of responses across tissues/endpoints, which is valuable to our mechanistic understanding of how benzo[a]pyrene induces genetic damage.Electronic supplementary materialThe online version of this article (doi:10.1007/s00204-017-2099-2) contains supplementary material, which is available to authorized users.
机译:基因损伤是肿瘤发生中的关键事件,化学诱导的遗传毒性作用是人类健康的关注点。尽管历史上已经使用定性筛选和结合方法解释了遗传毒性数据,但是人们对遗传毒性剂量反应数据的定量分析越来越感兴趣。我们证明了基准剂量(BMD)方法在根据经验对跨组织敏感性进行排名方面的新兴应用。使用模型环境致癌物,我们定量研究了扩展剂量范围内四个遗传损伤终点的反应,并使用BMD100值及其90%置信区间(CI)进行了跨组织敏感性排名。将MutaMouse标本口服暴露于11剂量的苯并[a] re。在多达8个组织中测量了DNA加合物频率和lacZ突变体频率(MF),并在未成熟(RET)和成熟红细胞(RBC)中评估了Pig-a MF和微核(MN)。 lacZ MF的跨组织BMD模式类似于DNA加合物所观察到的模式,并且与口服接触途径以及组织特异性代谢和增殖的差异相一致。 lacZ MF BMD与组织匹配的加合物BMD显着相关,表明跨组织一致的加合物转化率。对于Pig-a和MN端点,BMD CI对于RETs和RBCs都是重叠的,这表明两种细胞群在长期暴露中具有可比的效用。端点特定响应最大值的检查说明了比较跨端点的固定基准响应的BMD值的困难。总体而言,BMD方法允许对组织/端点之间的反应进行强有力的比较,这对于我们对苯并[a] how如何诱发遗传损伤的机理的理解非常有价值。电子补充材料本文的在线版本(doi:10.1007 / s00204-017 -2099-2)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号